SEC Filing Details
Document Details
Form
Filing Date
May 1, 2024
Document Date
Apr 29, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Akero Therapeutics, Inc.
Issuer
Akero Therapeutics, Inc.
Filer
Gangloff Scott A.